InvestorsHub Logo
Followers 6
Posts 202
Boards Moderated 0
Alias Born 11/12/2014

Re: None

Monday, 06/01/2015 2:24:43 PM

Monday, June 01, 2015 2:24:43 PM

Post# of 702793
News Coverage Today (there's probably more than listed here)

NW Bio Announces Data To Date From DCVax®-Direct ...
www.thestreet.com/.../nw-bio-announces-data-to-date-fro...
TheStreet, Inc.
4 hours ago - NW Bio Announces Data To Date From DCVax®-Direct Phase I Trial ... released promising new data on their Phase I trial of DCVax-Direct for ...
NW Bio Announces Data to Date From DCVax®-Direct ...
www.marketwatch.com/.../nw-bio-announces-data-to-date-fro...MarketWatch
3 hours ago - NW Bio Announces Data to Date From DCVax®-Direct Phase I Trial ... The trial tested three different dose levels of DCVax-Direct, two different ...
NW Bio Announces Data to Date From DCVax®-Direct ...
finance.yahoo.com/.../nw-bio-announces-data-date-1433...
Yahoo! Finance
4 hours ago - NW Bio Announces Data to Date From DCVax®-Direct Phase I Trial. 86% of Phase I patients treated with preferred method still alive.
NW Bio Announces Data to Date From DCVax®-Direct ...
www.ktvn.com/.../nw-bio-announces-data-to-date-from-dcvax-direct...KTVN
2 hours ago - NW Bio Announces Data to Date From DCVax®-Direct Phase I Trial .... new data on their Phase I trial of DCVax-Direct for direct injection into all ...
Northwest Biotherapeutics Announces Data To Date From ...
www.biospace.com/.../northwest-biotherapeutics-announces-data-to-date/...
2 hours ago - BETHESDA, Md., June 1, 2015 /PRNewswire/ -- Northwest ... Northwest Biotherapeutics (NWBO) Announces Data To Date From DCVax-Direct Phase I Trial ... ("NW Bio"), a U.S. biotechnology company developing DCVax® ...
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent NWBO News